Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19,168	18,363	22,073	27,883	44,467	26,843
Market Cap Growth	2.70%	-16.81%	-20.84%	-37.29%	65.66%	97.16%
Enterprise Value	21,470	20,749	25,782	28,964	44,979	27,038
Last Close Price	197.00	187.99	237.97	299.14	475.46	286.46
PE Ratio	85.20	104.87	71.14	31.83	107.31	79.91
Forward PE	40.16	46.49	49.64	31.48	60.28	60.80
PS Ratio	6.62	6.61	7.95	7.98	15.40	14.05
PB Ratio	4.75	4.56	8.26	11.09	25.66	18.37
P/TBV Ratio	-	-	-	46.41	163.54	112.24
P/FCF Ratio	38.61	38.63	80.91	153.46	117.67	104.17
P/OCF Ratio	24.32	22.53	29.57	45.54	63.35	64.39
PEG Ratio	1.84	2.29	6.24	1.67	6.53	3.09
EV/Sales Ratio	7.41	7.46	9.29	8.29	15.58	14.16
EV/EBITDA Ratio	30.13	32.97	39.20	24.20	43.61	46.83
EV/EBIT Ratio	48.49	52.40	54.93	27.47	48.88	53.74
EV/FCF Ratio	43.24	43.65	94.51	159.41	119.02	104.93
Debt / Equity Ratio	0.74	0.71	1.38	0.45	0.36	0.40
Debt / EBITDA Ratio	4.12	4.38	5.39	0.93	0.60	1.00
Debt / FCF Ratio	5.98	6.04	13.50	6.25	1.66	2.28
Asset Turnover	0.35	0.35	0.43	0.78	0.85	0.81
Inventory Turnover	2.15	2.01	1.62	1.85	2.13	2.27
Quick Ratio	1.06	1.05	0.49	0.53	0.59	0.59
Current Ratio	1.91	1.85	1.51	1.61	1.40	1.54
Return on Equity (ROE)	5.69%	5.33%	12.05%	41.43%	25.94%	25.56%
Return on Assets (ROA)	3.44%	3.10%	4.59%	14.62%	16.90%	13.38%
Return on Capital (ROIC)	4.07%	3.74%	5.86%	21.93%	26.10%	18.63%
Return on Capital Employed (ROCE)	6.10%	5.40%	6.90%	26.20%	31.60%	22.00%
Earnings Yield	1.17%	0.95%	1.41%	3.14%	0.93%	1.25%
FCF Yield	2.59%	2.59%	1.24%	0.65%	0.85%	0.96%
Dividend Yield	0.35%	0.37%	0.29%	0.48%	0.27%	0.24%
Payout Ratio	29.84%	38.32%	42.77%	13.25%	15.13%	9.33%
Buyback Yield / Dilution	-3.36%	-5.01%	0.00%	0.01%	0.00%	-0.00%
Total Shareholder Return	-3.01%	-4.64%	0.29%	0.50%	0.27%	0.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.